Dr. Hiroyuki Daiko Esophageal Cancer Surgery

Consultant - Esophageal Cancer Surgery , Experience:

Book Appointment

About Doctor

Dr. Hiroyuki Daiko is among the top esophageal cancer doctor in Tokyo, Japan.

Dr. Hiroyuki Daiko is associated with National Cancer Centre, Japan.

The Department of Esophageal Surgery, consisting of three staff surgeons and three

Residents, deals with neoplasms arising from the esophagus. The surgical management of esophageal cancer has been the main clinical research activity of this department. In particular, our department is striving to establish minimally invasive surgery that consists of neoadjuvant treatment followed by minimally invasive esophagectomy. Our department is conducting a study to define the role of surgery in the multimodal approach to the treatment of esophageal cancer, and is aiming for thoracolaparoscopic esophagectomy, which consists of thoracoscopic esophagectomy and laparoscopic reconstruction, to become a standard surgical procedure.

In 2018, 142 patients underwent esophagectomies, including 140 cases of thoracic esophageal cancer and two cases of cervical cancer. Transthoracic esophagectomies with extended lymph node dissection were performed on six cases. Thoracoscopic esophagectomies in the prone

position with radical lymph node dissection were undertaken in 128 cases. Mediastinoscopic

esophagectomy for patients above 80 or patients with multiple complications was undertaken in six cases. Postoperatively, within 30 days, three patients died due to complications after a salvage operation.


National Cancer Centre, Japan


  • Esophageal Cancer Surgery

Procedures Performed

  • Esophageal Cancer Surgery
  • Minimal invasive esophagectomy
  • Thoracolaparoscopic esophagectomy
  • Mediastinoscopic esophagectomy

Research & Publications

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy